bioAffinity Technologies, Inc. (BIAF)
9.82
-0.68
(-6.48%)
USD |
NASDAQ |
Sep 10, 12:28
bioAffinity Technologies Price to Book Value : 1.178 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 1.260 |
| September 08, 2026 | 1.072 |
| September 04, 2026 | 1.832 |
| September 03, 2026 | 1.533 |
| September 02, 2026 | 1.170 |
| September 01, 2026 | 0.7907 |
| August 31, 2026 | 0.5471 |
| August 28, 2026 | 0.5843 |
| August 27, 2026 | 0.6071 |
| August 26, 2026 | 0.6107 |
| August 25, 2026 | 0.6227 |
| August 24, 2026 | 0.6983 |
| August 21, 2026 | 0.7199 |
| August 20, 2026 | 0.7201 |
| August 19, 2026 | 0.7361 |
| August 18, 2026 | 0.8518 |
| August 17, 2026 | 0.7055 |
| August 14, 2026 | 0.7237 |
| August 13, 2026 | 0.6893 |
| August 12, 2026 | 0.8508 |
| August 11, 2026 | 0.8747 |
| August 10, 2026 | 0.8819 |
| August 07, 2026 | 0.9179 |
| August 06, 2026 | 0.9533 |
| August 05, 2026 | 0.9535 |
| Date | Value |
|---|---|
| August 04, 2026 | 0.9906 |
| August 03, 2026 | 1.075 |
| July 31, 2026 | 1.129 |
| July 30, 2026 | 1.160 |
| July 29, 2026 | 1.053 |
| July 28, 2026 | 1.131 |
| July 27, 2026 | 1.227 |
| July 24, 2026 | 1.188 |
| July 23, 2026 | 1.202 |
| July 22, 2026 | 1.274 |
| July 21, 2026 | 1.269 |
| July 20, 2026 | 1.258 |
| July 17, 2026 | 1.266 |
| July 16, 2026 | 1.281 |
| July 15, 2026 | 1.300 |
| July 14, 2026 | 1.277 |
| July 13, 2026 | 1.260 |
| July 10, 2026 | 1.380 |
| July 09, 2026 | 1.401 |
| July 08, 2026 | 1.42 |
| July 07, 2026 | 1.494 |
| July 06, 2026 | 1.455 |
| July 02, 2026 | 1.494 |
| July 01, 2026 | 1.518 |
| June 30, 2026 | 1.461 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 2.022 |
| Perspective Therapeutics, Inc. | 0.9864 |
| MiMedx Group, Inc. | 3.053 |
| Veracyte, Inc. | 2.485 |
| ABVC BioPharma, Inc. | 2.505 |
Price to Book Value Related Metrics
| PS Ratio | 0.4239 |
| Price | 9.82 |
| Earnings Yield | -1.05K% |
| Market Cap | 4.441M |